Reference is made to the stock exchange announcement on 25 September 2025
regarding the private placement under the financing facility with Long State
Investments Limited.

For clarity, the reference to a "placement commission on market terms" relates
to the standard transaction cost that applies when raising capital through such
facilities/underwriters. This type of commission is customary in the capital
markets and comparable to underwriting fees in larger placements. It does not
represent a special benefit to Long State but reflects the normal compensation
all underwriters receive when facilitating capital raises.

For further information, please contact:  
Ulrik Spork, COB Soft Solutions AS, +45 31 38 83 87
Ingrid Juven, CFO SoftOx Solutions AS, +47 918 76 165
Mail: ir@soft-ox.com  

About SoftOx Solutions AS: 
SoftOx Solutions AS (ticker: SOFTX) is a clinical-stage pharmaceutical company
listed on Euronext Growth Oslo. The company is developing highly effective
pan-antimicrobial pharmaceuticals targeting bacteria, viruses, and fungi. The
technology is based on extensive research and development in partnership with
leading Nordic research institutes.